Actos (pioglitazone) is a drug used to treat Type 2 Diabetes and has now been linked to bladder cancer. Patients that have used this drug for a period of two years or more have doubled their risk for bladder cancer.
Physicians are recommending that patients who have a history of bladder cancer or related conditions do not take this diabetes drug.
Actos increases the risk for bladder cancer by 83%. The risk of developing bladder cancer increases as the time the drug was taken increases. Those who took Actos for an extended period of time have a higher risk of bladder cancer.
The symptoms of developing bladder cancer after taking Actos include:
- Blood or red color in urine
- Increased urge to urinate
- Pain during urination
If you or a loved one has taken this Type 2 Diabetes drug and bladder cancer has developed as a result, call our attorneys at 800.637.8170. Our office believes that pharmaceutical companies should not be able to put profit ahead of patient health.